Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Feierstein v. Correvio Pharma Corp. et al
Case Number:
1:19-cv-11361
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
November 20, 2020
Judge Gives Initial OK To Correvio Pharma $1.75M Class Deal
A New York federal judge gave preliminary approval Thursday to a $1.75 million class action settlement that would end litigation alleging Canadian pharmaceutical company Correvio Pharma Corp. misled shareholders about the likelihood of a heart drug gaining approval by the U.S. Food and Drug Administration.
-
July 01, 2020
Canadian Pharma Co. Wants Investors' Stock-Drop Suit Nixed
A Canadian pharmaceutical company asked a New York federal judge Tuesday to toss a proposed stock-drop class action that alleges the company misled shareholders about the likelihood of a drug gaining approval from the U.S. Food and Drug Administration, saying the company was transparent about the process.